Section 1
Changes introduced with TDSG-LD 203 Release 02 from TDSG-LD 202 Release 03
There have been changes made to the following entries:
Acupuncture
Animal Bite
Ankylosing Spondylitis
Anti-Androgens
Antibiotic Therapy
Antidepressant Therapy
Arthritis
Autoimmune Disease
Bipolar Disorder
Bleeding Disorder
Cardiomyopathy
Cardiovascular Disease
Chikungunya Virus
Chlamydia
Cirrhosis
Colitis
Communication Difficulties
Depression
Disabled Donor
Disease of Unknown Aetiology
Ehlers-Danlos Syndrome (Disease)
Elliptocytosis
Endocarditis
Endoscopy
Episcleritis
Eye Disease
Gall Bladder Disease
German Measles
Haemoglobin Disorders
Haemolytic Anaemia
Hepatitis B
Hepatitis B - Post Immunization
Hepatitis C
Hepatitis of Unknown Origin
Hereditary Elliptocytosis
Hormone Replacement Therapy
Immune Thrombocytopenia
Immunoglobulin Therapy
Immunosuppression
Infection - Acute
Infection - Chronic
Inflammatory Eye Disease
Inoculation Injury
Jaundice
Mental Health Problems
Myeloproliferative Syndrome
Pituitary Extract - Human
Platelet Disorder
Polymyalgia Rheumatica
Prion Associated Diseases
Psoriasis
Rheumatoid Arthritis
Scleritis
Sexually Transmitted Disease
Shingles
Skin Disease
Steroid Therapy
Subacute Bacterial Endocarditis
Surgery
Syphilis
Temporal Arteritis
Thrombocytosis
Thyroid Disease
Tigason
Tissue and Organ Recipients
Transfusion
West Nile Virus
Section 2
Changes to TDSG-LD 203 after Release 02
See: Latest Updates
This appendix was last updated in TDSG-LD Edition 203, Release 02